Filipp F. Vasilev
Yakutsk, SA, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Triclabendazole suppresses cellular levels of glycosaminoglycan-A potential therapeutic agent for mucopolysaccharidoses and related diseases.
Journal: iScience
Published: December 02, 2024
Protein-Variant-Phenotype Study of NBAS Using AlphaFold in the Aspect of SOPH Syndrome.
Journal: Proteins
Published: July 13, 2024
HOPS, CORVET and newly-identified Hybrid tethering complexes contribute differentially towards multiple modes of endocytosis.
Journal: Scientific reports
Published: August 18, 2023
A Case of Mucopolysaccharidosis II Caused by a Novel Variant with Skin Linear Hyperpigmented Streaks along Blaschko's Lines.
Journal: International journal of molecular sciences
Published: February 14, 2023
Origins of SOPH syndrome: A study of 93 Yakut patients with review of C-terminal phenotype.
Journal: Clinical genetics
Published: November 22, 2022
Hematopoietic Disorders, Renal Impairment and Growth in Mucopolysaccharidosis-Plus Syndrome.
Journal: International journal of molecular sciences
Published: May 02, 2022
Mucopolysaccharidosis-Plus Syndrome.
Journal: International journal of molecular sciences
Published: December 09, 2019
Biallelic VPS35L pathogenic variants cause 3C/Ritscher-Schinzel-like syndrome through dysfunction of retriever complex.
Journal: Journal of medical genetics
Published: April 09, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026